Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M

Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M

Aragó, M.; Moreno-Felici, J.; Abás, S.; Rodríguez-Arévalo, S.; Hyrossova, P.; Figuera, A.; Viñals, F.; Pérez, B.; Loza, M. I.; Brea, J.; Latorre, P.; Carrodeaguas, J. A.; García-Rovés, P. M.; Galdeano, C.; Ginex, T.; Luque, F. J.; Escolano, C.; Perales, J. C.

Biomedicine & Pharmacotherapy, 2020, 121, 109601.

https://www.sciencedirect.com/science/article/pii/S0753332219352230